OptimizeRx (OPRX) News Today → Elon Musk’s Next Move Will Disrupt AI Forever (From InvestorPlace) (Ad) Free OPRX Stock Alerts $10.54 -0.27 (-2.50%) (As of 05/13/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 12 at 1:40 AM | americanbankingnews.comOptimizeRx (OPRX) to Release Earnings on TuesdayMay 7, 2024 | marketbeat.comOptimizeRx (OPRX) Set to Announce Earnings on TuesdayOptimizeRx (NASDAQ:OPRX) will be releasing earnings after the market closes on Tuesday, May 14, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=590375)May 7, 2024 | americanbankingnews.comOptimizeRx Co. (NASDAQ:OPRX) Receives Consensus Recommendation of "Moderate Buy" from AnalystsMay 6, 2024 | globenewswire.comOptimizeRx to Participate in Upcoming Investor ConferencesApril 29, 2024 | markets.businessinsider.comBuy Rating Reaffirmed for AbbVie: Future Growth Beyond Humira’s CompetitionApril 28, 2024 | marketbeat.comFederated Hermes Inc. Has $2.62 Million Holdings in OptimizeRx Co. (NASDAQ:OPRX)Federated Hermes Inc. lowered its position in shares of OptimizeRx Co. (NASDAQ:OPRX - Free Report) by 47.3% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 182,985 shares of the company's stock after selling 1April 26, 2024 | globenewswire.comOptimizeRx Provides Business Update and Sets First Quarter 2024 Conference Call for May 14, 2024 at 4:30 p.m. ETApril 18, 2024 | globenewswire.comOptimizeRx Releases 2024 Environmental, Social, and Governance (ESG) ReportApril 16, 2024 | marketbeat.comOptimizeRx (NASDAQ:OPRX) Earns "Market Outperform" Rating from JMP SecuritiesJMP Securities reissued a "market outperform" rating and set a $15.00 price target on shares of OptimizeRx in a report on Tuesday.April 16, 2024 | globenewswire.comOptimizeRx Reports Strong Fourth Quarter and Full Year 2023 Financial ResultsApril 13, 2024 | stockhouse.comOptimizeRx Named America's Fastest-Growing Company for Fifth Year in a RowApril 11, 2024 | finance.yahoo.comOptimizeRx Named America’s Fastest-Growing Company for Fifth Year in a RowApril 11, 2024 | finance.yahoo.comOptimizeRx Named America’s Fastest-Growing Company for Fifth Year in a RowApril 11, 2024 | globenewswire.comOptimizeRx Named America's Fastest-Growing Company for Fifth Year in a RowApril 6, 2024 | investorplace.com7 Top Undervalued Stocks Primed for a Multibagger RecoveryApril 4, 2024 | markets.businessinsider.comOptimizeRx: A Strong Buy on Strategic Acquisitions and Innovative Platform ExpansionApril 4, 2024 | marketbeat.comJMP Securities Begins Coverage on OptimizeRx (NASDAQ:OPRX)JMP Securities started coverage on shares of OptimizeRx in a report on Thursday. They issued an "outperform" rating and a $15.00 price objective on the stock.April 2, 2024 | au.lifestyle.yahoo.comTesla blames sales drop on Houthi attacks and arson in GermanyApril 1, 2024 | msn.comAriana Madix To Host ‘Love Island USA’ as Sarah Hyland Departs FranchiseApril 1, 2024 | au.news.yahoo.comCanoo spent double its annual revenue on the CEO’s private jet in 2023April 1, 2024 | finance.yahoo.comOptimizeRx Corporation (NASDAQ:OPRX) Q4 2023 Earnings Call TranscriptApril 1, 2024 | marketbeat.comOptimizeRx (NASDAQ:OPRX) Stock Rating Reaffirmed by Stifel NicolausStifel Nicolaus reissued a "buy" rating and set a $13.00 price target on shares of OptimizeRx in a report on Monday.March 29, 2024 | finance.yahoo.comQ4 2023 OPTIMIZERx Corp Earnings CallMarch 28, 2024 | investorplace.comOPRX Stock Earnings: OptimizeRx Beats Revenue for Q4 2023March 28, 2024 | msn.comOptimizeRx Q4 revenue $28.4MMarch 27, 2024 | msn.comOptimizeRx Q4 2023 Earnings PreviewMarch 27, 2024 | benzinga.com7OPRX : OptimizeRx Earnings PreviewMarch 25, 2024 | globenewswire.comOptimizeRx Sets Fourth Quarter 2023 Conference Call for March 28, 2024 at 8:30 a.m. ETMarch 23, 2024 | seekingalpha.comOptimizeRx: Exponential Growth Drives The Valuation CheaperMarch 13, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: OptimizeRx (OPRX), AnaptysBio (ANAB) and REPRO-MED Systems (KRMD)March 11, 2024 | markets.businessinsider.comOptimizeRx Provides an Update on the Timing of Earnings Call and Reaffirms Prior Revenue and Adjusted EBITDA Estimates for FY2023March 11, 2024 | globenewswire.comOptimizeRx Provides an Update on the Timing of Earnings Call and Reaffirms Prior Revenue and Adjusted EBITDA Estimates for FY2023March 8, 2024 | marketbeat.comKennedy Capital Management LLC Buys Shares of 555,675 OptimizeRx Co. (NASDAQ:OPRX)Kennedy Capital Management LLC purchased a new position in OptimizeRx Co. (NASDAQ:OPRX - Free Report) in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 555,675 shares of the company's stock, valued at approximately $March 6, 2024 | stockhouse.comOptimizeRx Powers Walmart's 'Specialty Pharmacies of the Community' Outreach EffortMarch 4, 2024 | globenewswire.comOptimizeRx Powers Walmart's ‘Specialty Pharmacies of the Community' Outreach EffortMarch 2, 2024 | marketbeat.comOptimizeRx Co. (NASDAQ:OPRX) Stock Holdings Lowered by Avenir CorpAvenir Corp lowered its position in shares of OptimizeRx Co. (NASDAQ:OPRX - Free Report) by 19.4% in the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 307,549 shares of the company's stock after selling 74,111 shares during the period. OptimizeRx accounts for 0.February 23, 2024 | benzinga.comOptimizeRx Stock (NASDAQ:OPRX), Short Interest ReportFebruary 21, 2024 | globenewswire.comOptimizeRx to Participate in Upcoming Investor ConferencesFebruary 13, 2024 | marketbeat.comOptimizeRx Co. (NASDAQ:OPRX) Short Interest Down 19.6% in JanuaryOptimizeRx Co. (NASDAQ:OPRX - Get Free Report) saw a significant decrease in short interest in January. As of January 31st, there was short interest totalling 778,800 shares, a decrease of 19.6% from the January 15th total of 968,400 shares. Based on an average daily trading volume, of 163,900 shares, the days-to-cover ratio is currently 4.8 days. Currently, 4.9% of the company's shares are sold short.January 28, 2024 | marketbeat.comOptimizeRx Co. (NASDAQ:OPRX) Given Consensus Rating of "Moderate Buy" by BrokeragesOptimizeRx Co. (NASDAQ:OPRX - Get Free Report) has earned a consensus rating of "Moderate Buy" from the eight brokerages that are presently covering the stock, Marketbeat Ratings reports. One investment analyst has rated the stock with a hold rating and seven have given a buy rating to the companJanuary 17, 2024 | marketbeat.comJacob Asset Management of New York LLC Buys 85,720 Shares of OptimizeRx Co. (NASDAQ:OPRX)Jacob Asset Management of New York LLC lifted its stake in shares of OptimizeRx Co. (NASDAQ:OPRX - Free Report) by 30.1% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 370,330 shares of the company's stock after purchasJanuary 12, 2024 | marketbeat.comBrokers Issue Forecasts for OptimizeRx Co.'s FY2023 Earnings (NASDAQ:OPRX)OptimizeRx Co. (NASDAQ:OPRX - Free Report) - Stock analysts at William Blair cut their FY2023 EPS estimates for OptimizeRx in a report released on Tuesday, January 9th. William Blair analyst R. Daniels now anticipates that the company will earn ($0.60) per share for the year, down from their prevJanuary 11, 2024 | marketbeat.comOptimizeRx Co. (NASDAQ:OPRX) General Counsel Marion Odence-Ford Sells 4,000 SharesOptimizeRx Co. (NASDAQ:OPRX - Get Free Report) General Counsel Marion Odence-Ford sold 4,000 shares of OptimizeRx stock in a transaction that occurred on Tuesday, January 9th. The stock was sold at an average price of $15.19, for a total transaction of $60,760.00. Following the transaction, the general counsel now directly owns 11,114 shares in the company, valued at $168,821.66. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.January 11, 2024 | marketbeat.comQ4 2024 Earnings Forecast for OptimizeRx Co. Issued By William Blair (NASDAQ:OPRX)OptimizeRx Co. (NASDAQ:OPRX - Free Report) - Equities researchers at William Blair cut their Q4 2024 EPS estimates for shares of OptimizeRx in a research note issued to investors on Tuesday, January 9th. William Blair analyst R. Daniels now forecasts that the company will post earnings of $0.20 pJanuary 10, 2024 | marketbeat.comRoyal Bank of Canada Raises OptimizeRx (NASDAQ:OPRX) Price Target to $17.00Royal Bank of Canada boosted their price target on shares of OptimizeRx from $14.00 to $17.00 and gave the stock an "outperform" rating in a research note on Wednesday.January 9, 2024 | finanznachrichten.deOptimizeRx Corporation: OptimizeRx Preannounces Select Expected 2023 Financials and Provides a Business UpdateJanuary 9, 2024 | finance.yahoo.comOptimizeRx Preannounces Select Expected 2023 Financials and Provides a Business UpdateJanuary 4, 2024 | msn.comBarclays Initiates Coverage of OptimizeRx (OPRX) with Equal-Weight RecommendationJanuary 3, 2024 | marketbeat.comBarclays Initiates Coverage on OptimizeRx (NASDAQ:OPRX)Barclays started coverage on OptimizeRx in a report on Wednesday. They set an "equal weight" rating and a $15.00 target price on the stock.January 3, 2024 | marketbeat.comOptimizeRx Co. (NASDAQ:OPRX) Given Consensus Recommendation of "Buy" by AnalystsOptimizeRx Co. (NASDAQ:OPRX - Get Free Report) has been assigned an average rating of "Buy" from the eight brokerages that are presently covering the firm, MarketBeat Ratings reports. Eight investment analysts have rated the stock with a buy rating. The average 1 year price objective among analyst Get OptimizeRx News Delivered to You Automatically Sign up to receive the latest news and ratings for OPRX and its competitors with MarketBeat's FREE daily newsletter. Email Address America could fall from this event (Ad)America’s “Internal Enemies” Exposed New documentary exposes a hidden election plan in Washington D.C. that, if successful, could be more financially and culturally devastating than the dot-com blowup of 2000, the 2008 financial crisis, or the COVID crash. Click here to see how you can protect yourself today. OPRX Media Mentions By Week OPRX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. OPRX News Sentiment▼0.410.51▲Average Computer and Technology News Sentiment OPRX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. OPRX Articles This Week▼52▲OPRX Articles Average Week Get OptimizeRx News Delivered to You Automatically Sign up to receive the latest news and ratings for OPRX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Rimini Street News ZeroFox News DHI Group News Steel Connect News Marchex News Edgio News Emerald News Resources Connection News Zhihu News Liquidity Services News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:OPRX) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersGuard Against the Coming Financial UpheavalPorter & CompanyClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaElon’s New Device is About to Shock the WorldInvestorPlaceCharles Payne Demystifies OptionsUnstoppable ProsperityForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressGold ManiaStansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OptimizeRx Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
